FindTrial
Sign In

A study to compare the effects of 0.5% Hyperbaric Bupivacaine and 0.5% Hyperbaric Levobupivacaine for Spinal Anaesthesia in Lower Abdominal Surgery

A comparative study of the effects of 0.5% Hyperbaric Bupivacaine and 0.5% Hyperbaric levobupivacaine for spinal anaestheisia in lower abdominal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050134
Enrollment
70
Registered
2023-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Angana Nath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing lower abdominal surgery 2. Patients with ASA status 1-2 3. Patients in the age group of 18-35 years 4. Patients who have given informed and written consent

Exclusion criteria

Exclusion criteria: 1. Patients with spinal deformity 2. Patients with allergy to study drugs 3. patients with drug / alcohol abuse 4. Patients with BMI >29 kg/metre square 5. Patients with diabetes mellitus 6. Patients with raised intracranial pressure 7. Patients with local infection at the site of spinal anaesthesia 8. Patients with previous spinal surgery, if any 9. Patients on anticoagulants, with coagulopathies 10. Patients posted for ceasarean section

Design outcomes

Primary

MeasureTime frame
To compare the duration of analgesia of each groupTimepoint: To compare the duration of analgesia of each group at the end of operation—

Secondary

MeasureTime frame
To compare the duration of analgesia of each groupTimepoint: To compare the duration of analgesia of each group at the end of operation—

Countries

India

Contacts

Public ContactDr Angana Nath

Gauhati Medical College and Hospital

rajibhazarika8@gmail.com9706063140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026